AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
GADOPENTETATE DIMEGLUMINE
11 registrations across 3 African markets— 9 active
Markets with GADOPENTETATE DIMEGLUMINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| MAGNEGITA 100 ml | 🇿🇦South Africa | Medicine Developers International (Pty) Ltd | suspended | Jul 2018 |
| MAGNEGITA 10 ml | 🇿🇦South Africa | Medicine Developers International (Pty) Ltd | suspended | Dec 2012 |
| MAGNEVIST 10 ml | 🇿🇦South Africa | Bayer (Pty) Ltd û Isando | active | Jan 1900 |
| MAGNEVIST 100 ml | 🇿🇦South Africa | Bayer (Pty) Ltd û Isando | active | Jan 1900 |
| MAGNEVIST 20 ml | 🇿🇦South Africa | Bayer (Pty) Ltd û Isando | active | Jan 1900 |
| MAGNEVIST 5 ml | 🇿🇦South Africa | Bayer (Pty) Ltd û Isando | active | Jan 1900 |
| MAGNEVIST 15 ml | 🇿🇦South Africa | Bayer (Pty) Ltd û Isando | active | Jan 1900 |
| MAGNEVIST 30 ml | 🇿🇦South Africa | Bayer (Pty) Ltd û Isando | active | Jan 1900 |
| GADOPENTETATE
DIMEGLUMINE PARENTERAL
ORDINARY VIALS | 🇺🇬Uganda | UNIQUE PHARMACEUTICA L LABORATORIES. (A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICA LS LTD) | active | — |
| Magnilek Solution for injection | 🇹🇿Tanzania | UNIQUE PHARMACEUTICAL LABORATORIES (A Div. of J. B. Chemicals & Pharmaceuticals Ltd) | active | — |
| GADOPENTETATE
DIMEGLUMINE PARENTERAL
ORDINARY VIALS | 🇺🇬Uganda | UNIQUE PHARMACEUTICA L LABORATORIES. (A DIVISION OF J.B. CHEMICALS AND PHARMACEUTICA LS LTD) | active | — |
GADOPENTETATE DIMEGLUMINE in Africa — Regulatory Overview
GADOPENTETATE DIMEGLUMINE is registered across 3 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Uganda, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.
Of the 11 registrations, 9 (82%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.